Second Time’s The Charm: Amylyx’s ALS Drug Wins US FDA Panel Nod

 
• By Sue Sutter
  
Yes and no
Amylyx flipped several votes from "no" to "yes" in its second visit to the advisory committee. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers